Biological E

Gary Dubin, President, Global Vaccine Business Unit, Takeda, and Dion Warren, Head of Multi-Country Organization, India &…

The partnership will build upon existing manufacturing capacity for the vaccine at Takeda’s facility in Singen, Germany and…

According to respective company sources, Biological E is holding 200 million doses of its COVID-19 vaccine Corbevax, while Bharat…

CORBEVAX is expected to be available as a Booster dose on the CoWIN App in public and private vaccination centres from August 12,…

The DCGI recently approved Corbevax as a precaution dose for those aged 18 and above

The decision comes within weeks of Biological E receiving the Emergency Use Authorisation (EUA) for children between five and 12…

According to an internal document circulated to the members of the Empowered Group-5 on COVID-19 Vaccination, which will be…

The approval has been granted to Covaxin, ZyCov-D and Corbevax

Biological E's Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years

WHO and partners will work with the Indian government and Bio E to develop a roadmap and put in place the necessary training and…